ConductScience.org, home

Comparison · NCT03846544-eab6d03b

Double Pick up Group vs Control Group: Live Birth Rates

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Double Pick up Group vs Control Group: Live Birth Rates. Trial comparisons, record NCT03846544-eab6d03b. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03846544-eab6d03b

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.3480.1880.551wilson
Risk in group 20.2610.1250.465wilson
Risk difference, group 1 minus group 20.087-0.1720.331newcombe hybrid score
Risk ratio, group 1 over group 21.330.5493.24log
Odds ratio, group 1 over group 21.510.4265.36log
Number needed to treat, for one more participant with the outcome on Double Pick up Group than on Control Group11.5from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: control.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Double Pick up Group
CFA-double pick up: In the study group, 225 IU of rFSH will continue after the first oocyte retrieval (OR). Antagonist administration will be initiated when at least one follicle measuring ≥14 mm will be present in the ultrasound. If one or more follicles ≥17 mm are observed, patients will undergo a second triggering with hCG 5000 IU and a second OR will be performed. In case of patients with no follicular development following 10 additional days of rFSH post-OR
823OG001
Group 2Control Groupconventional stimulation group623OG000

Outcome

Type
SECONDARY
Title
Live Birth Rates
Description
number of live births
Time frame
12 months
Population

Source ClinicalTrials.gov

Trial

Title
Double Pick up in Poor Prognosis Women
NCT number
NCT03846544
Phases
PHASE4
Conditions
Fertility Disorders
Interventions
Corifollitoropin alfa (CFA)-double pick up
Lead sponsor
CRG UZ Brussel
Results first posted
2024-04-15

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03846544-eab6d03b